F-Term-List

C12N15/00@A;15/00@B;15/00@C;15/00@D;15/00@F;15/00@G;15/00@H;15/00@J;15/00@K;15/00@L

AA00
FIELD OF APPLICATION

AA01

AA03

AA05

AA07

AA08

AA10

. Medicines for treatment or prevention

. Chemical industries

. Foods or brewing

. Agriculture

. . Plant breeding

. Animal husbandries and fisheries

AA11

AA12

AA13

AA14

AA15

AA17

AA19

AA20

. Analysis or diagnosis

. . Cancers or tumours

. . Infectious diseases

. . . Viral infections

. . Cell surface antigens

. Resources energy or environmental protection

. Apparatus electronics

. Genetic engineering basic technologies or others

BA00
PRODUCTION SUBSTANCE TO BE TARGETED

BA01

BA02

BA03

BA04

BA05

BA07

BA08

BA09

BA10

. Hormones or autacoids

. . Insulins or insulin-like growth factors (IGF)

. . Growth hormones or growth hormone-releasing factors (GRF)

. . Diuresis antihypertensive peptides or atrial natriuretic peptides (ANP)

. . Opiate peptides or analgesic hormones

. Enzymes

. . Oxidoreductases (EC1)

. . . Superoxide dismutases (SOD)

. . Transferases (EC2)

BA11

BA12

BA13

BA14

BA15

BA16

BA17

BA19

. . Hydrolases (EC3)

. . . acting on glycosyl compounds (EC3.2)

. . . . Alpha-amylases or beta-amylases

. . . acting on peptide bonds (EC3.4)

. . . . Tissue plasminogen activators (t-PA).

. . . . Urokinases

. . . . Chymosins or rennins

. Protease inhibitors

BA21

BA22

BA23

BA24

BA25

BA26

BA27

BA28

BA29

BA30

. Cytokines or lymphokines

. . Interferons (IFN)

. . . Alpha-interferons

. . . Beta-interferons

. . . Gamma-interferons

. . Interleukins

. . . Interleukin-2 (IL-2)

. . Tumour necrosis factors (TNF)

. . Lymphotoxins

. . Colony stimulating factors (CSF)

BA31

BA32

BA33

BA34

BA35

BA36

BA38

BA40

. Antigenic peptides for vaccines

. . Viral proteins

. . . Hepatitis viruses

. . . Polioviruses

. . . Human immunodeficiency viruses (HIV)

. . Tumour antigens

. Toxins excluding antigenic proteins

. Serum albumins

BA41

BA42

BA43

BA44

BA45

BA46

BA47

BA48

BA49

BA50

. Monoclonal antibodies

. . Immunogens being biological materials

. . . Biological materials derived from animals

. . . . derived from human cells

. . . . . Human tumour cells

. . . . . Human lymph cells

. . . Biological materials derived from plants

. . . Biological materials derived from microorganisms

. . . . derived from fungi or microbial fungi

. . . . derived from bacteria

BA51

BA53

BA54

BA55

BA56

BA57

BA58

. . . . derived from viruses

. . Immunogens being non-biological materials i.e. chemical substances

. . . Tumour antigenic substances

. . . Hormones

. . . Cytokines

. . . . Interferons (IFN)

. . . Antibodies

BA61

BA63

BA65

BA67

. Antibody proteins excluding monoclonal antibodies

. Receptor proteins

. Lipoproteins

. Antibiotics

BA71

BA72

BA73

BA74

BA75

BA77

BA79

BA80

. Amino acids

. . Lysines

. . Threonines

. . Glutamines or glutamic acids

. . Tryptophans

. Fermented foods

. Edible or ornamental plants

. Others

CA00
KIND OF NUCLEOTIDE FRAGMENT

CA01

CA02

CA03

CA04

CA05

CA06

CA07

CA09

CA10

. DNA

. . Structural genes

. . . Cutting from chromosomes

. . . cDNA

. . . Synthetic genes

. . . Modification genes

. . . encoding fusion proteins

. . Probes

. . Linkers

CA11

CA12

CA20

. RNA

. . mRNA

. Others

DA00
HOST

DA01

DA02

DA03

DA05

DA06

DA07

DA08

DA09

DA10

. Plant cells

. Animal cells

. . Human cells

. Bacteria

. . Escherichia coli (E. coli)

. . Bacillus

. . Streptomyces

. . Pseudomonas

. . Coryne types

DA11

DA12

DA20

. Fungi

. . Yeasts

. Others

EA00
KIND OF VECTOR

EA01

EA02

EA03

EA04

EA05

EA06

EA10

. Plant viruses

. Animal viruses

. Bacteriophages

. Plasmids

. . Wild plasmids

. . Cosmid vectors

. Others

FA00
IMPROVEMENT OR FUNCTION OF VECTOR

FA01

FA02

FA03

FA04

FA05

FA06

FA07

FA08

FA10

. Control of transcription or translation

. . Promoters or operators

. . . derived from trp-operons

. . . derived from lac-operons

. . . derived from lambda-phages

. . Enhancers

. . Terminators

. . Ribosome bonding sites

. Markers

FA11

FA13

FA15

FA17

FA18

FA20

. Stabilising injected DNA

. Amplifying copy numbers

. Expansion of host ranges e.g. shuttle vectors

. Secretion of products

. . Signal sequences

. Others

GA00
TECHNOLOGY FOR HANDLING CELL OR MICROORGANISM

GA01

GA02

GA03

GA04

GA05

GA06

GA07

GA08

GA09

GA10

. Cell fusions

. . Origins of parent cells

. . . Animals

. . . . at least one derived from humans

. . . . at least one derived from hybridomas

. . . Plants

. . . Microorganisms

. . Regulation methods for parent cells

. . Fusion means and apparatus used therefor

. . . Electrical fusions

GA11

GA12

GA13

GA14

GA16

GA17

GA18

GA19

. Injection of genes or plasmids

. . Microinjections

. . Ribosome methods

. . Electroporations

. Culture methods or culture apparatus

. . Plant cells or calluses

. . Animal cells

. . Microorganisms

GA21

GA23

GA25

GA27

GA30

. Protoplastisation

. Immortalisation or canceration of cells

. Mutations

. Isolation or screening of cells

. Others

HA00
TECHNOLOGY RELATED TO GENETIC ENGINEERING

HA01

HA03

HA04

HA06

HA08

HA09

. Protein engineering

. Isolation or purification of products or proteins

. . using monoclonal antibodies

. Activating or stabilising proteins

. Enzymes related to genetic engineering

. . Restriction enzymes

HA11

HA12

HA13

HA14

HA15

HA17

HA19

HA20

. Analysis or diagnosis methods and apparatus therefor

. . using DNA probes

. . . Labels or crosslinking agents

. . . Hybridisation conditions

. . using monoclonal antibodies

. Gene therapy methods

. Methods or apparatus for DNA synthesis and sequencing

. Others

4B024	MUTATION OR GENETIC ENGINEERING
	C12N15/00 -15/90,104@Z